Clinical Trial Update: Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

Early-phase clinical trial exploring mesenchymal stem cells for recurrent pregnancy loss; phase 1 and phase 2, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Loss

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Conditions: Recurrent Pregnancy Loss | Phase 1, Phase 2 | Status: UNKNOWN